NYSEARCA:ALTiShares Diversified Alternatives Trust Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding iShares Diversified Alternatives Trust Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $22.35 +2.13 (+10.53 %) (As of 07/10/2020 04:00 PM ET) Add Compare Share Today's Range$19.32Now: $22.35▼$24.3950-Day Range$6.05MA: $8.72▼$17.0352-Week Range$1.51Now: $22.35▼$24.65Volume17.92 million shsAverage Volume2.78 million shsMarket Capitalization$347.03 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileAnalyst RatingsAdvanced ChartCompetitorsEarningsFinancialsInsider TradesHeadlinesOptions ChainSEC FilingsSocial Media Altimmune, Inc., a clinical stage biopharmaceutical company, focused developing treatments for liver disease, immune modulating therapies, and vaccines. The company develops HepTcell, an immunotherapeutic product candidate that has completed Phase I clinical trial for patients chronically infected with the hepatitis B virus; NasoShield, an anthrax vaccine to provide for protection after a single intranasal administration; NasoVAX, a recombinant intranasal vaccine product candidate; and AdCOVID, a single-dose intranasal vaccine to protect against COVID-19 Its preclinical stage products include ALT-801, a novel peptide-based dual GLP-1/Glucagon receptor agonist for the treatment of non-alcoholic steatohepatitis; and ALT-702, an investigational tumor immunostimulant for treating cancer. The company also develops veterinary product candidates. It has a collaboration with the University of Alabama at Birmingham for the development of AdCOVID. Altimmune, Inc. is headquartered in Gaithersburg, Maryland.Read More Beat the Market (BTM) Rank™ 1.5 Analyst's Opinion Consensus RatingiShares Diversified Alternatives Trust has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $8.30, iShares Diversified Alternatives Trust has a potential downside of 62.9% from its current price of $22.35.Amount of Analyst CoverageiShares Diversified Alternatives Trust has received no research coverage in the past 90 days. Previous Next 2.4 Community Rank Outperform VotesiShares Diversified Alternatives Trust has received 66 “outperform” votes. (Add your “outperform” vote.)Underperform VotesiShares Diversified Alternatives Trust has received 72 “underperform” votes. (Add your “underperform” vote.)Community SentimentiShares Diversified Alternatives Trust has received 52.17% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about iShares Diversified Alternatives Trust and other stocks. Vote “Outperform” if you believe ALT will outperform the S&P 500 over the long term. Vote “Underperform” if you believe ALT will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldiShares Diversified Alternatives Trust does not currently pay a dividend.Dividend GrowthiShares Diversified Alternatives Trust does not have a long track record of dividend growth. Previous Next 3.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, iShares Diversified Alternatives Trust insiders have bought 2,306.37% more of their company's stock than they have sold. Specifically, they have bought $19,604,853.00 in company stock and sold $814,708.00 in company stock. Previous Next 0.0 Earnings and Valuation Previous Next Analyst Opinion: 1.5Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 3.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.38 out of 5 stars Industry, Sector and Symbol Stock Exchange NYSEARCA Industry Biotechnology Sub-IndustryN/A SectorMedical Current SymbolNYSEARCA:ALT Previous Symbol CUSIPN/A CIK1326190 Webwww.ishares.com Phone+1-415-6702000Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees25 Outstanding Shares15,527,000Market Cap$347.03 million Next Earnings Date8/11/2020 (Estimated) OptionableOptionable AMEX:ALT Rates by TradingView Receive ALT News and Ratings via Email Sign-up to receive the latest news and ratings for ALT and its competitors with MarketBeat's FREE daily newsletter. iShares Diversified Alternatives Trust (NYSEARCA:ALT) Frequently Asked Questions How has iShares Diversified Alternatives Trust's stock been impacted by COVID-19 (Coronavirus)? iShares Diversified Alternatives Trust's stock was trading at $3.19 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, ALT shares have increased by 600.6% and is now trading at $22.35. View which stocks have been most impacted by Coronavirus. Do Wall Street analysts recommend investors buy shares of iShares Diversified Alternatives Trust? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for iShares Diversified Alternatives Trust in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for iShares Diversified Alternatives Trust. When is iShares Diversified Alternatives Trust's next earnings date? iShares Diversified Alternatives Trust is scheduled to release its next quarterly earnings announcement on Tuesday, August 11th 2020. View our earnings forecast for iShares Diversified Alternatives Trust. How were iShares Diversified Alternatives Trust's earnings last quarter? iShares Diversified Alternatives Trust (NYSEARCA:ALT) issued its quarterly earnings data on Wednesday, May, 13th. The company reported ($0.26) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.32) by $0.06. The firm had revenue of $2.21 million for the quarter, compared to analysts' expectations of $0.50 million. View iShares Diversified Alternatives Trust's earnings history. When did iShares Diversified Alternatives Trust's stock split? How did iShares Diversified Alternatives Trust's stock split work? iShares Diversified Alternatives Trust shares reverse split before market open on Friday, September 14th 2018. The 1-30 reverse split was announced on Thursday, September 13th 2018. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, September 13th 2018. An investor that had 100 shares of iShares Diversified Alternatives Trust stock prior to the reverse split would have 3 shares after the split. What price target have analysts set for ALT? 1 brokers have issued twelve-month price objectives for iShares Diversified Alternatives Trust's shares. Their forecasts range from $8.30 to $8.30. On average, they expect iShares Diversified Alternatives Trust's stock price to reach $8.30 in the next year. This suggests that the stock has a possible downside of 62.9%. View analysts' price targets for iShares Diversified Alternatives Trust. Has iShares Diversified Alternatives Trust been receiving favorable news coverage? News coverage about ALT stock has trended very negative on Sunday, according to InfoTrie Sentiment Analysis. InfoTrie scores the sentiment of news coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. iShares Diversified Alternatives Trust earned a news impact score of -3.2 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the stock's share price in the near future. View the latest news about iShares Diversified Alternatives Trust. Who are some of iShares Diversified Alternatives Trust's key competitors? Some companies that are related to iShares Diversified Alternatives Trust include Aptose Biosciences (APS), Oxford BioMedica (OXB), CEL-SCI (CVM), Cel-Sci (CVM), Paradigm Biopharmaceuticals (PAR), SIGA Technologies (SIGA), Biotest (BIO), Neptune Wellness Solutions (NEPT), TELIX Pharmaceutical (TLX), Starpharma (SPL), Silence Therapeutics (SLN), ProMetic Life Sciences (PLI), Pfenex (PFNX), IMV (IMV) and Emblem (EMC). View all competitors. What other stocks do shareholders of iShares Diversified Alternatives Trust own? Based on aggregate information from My MarketBeat watchlists, some companies that other iShares Diversified Alternatives Trust investors own include AbbVie (ABBV), Amplify Energy (AMPY), Amplify Energy (AMPY), Aravive (ARAV), CAN-FITE BIOPHA/S (CANF), Corbus Pharmaceuticals (CRBP), Carvana (CVNA), Energy Transfer LP Unit (ET), Goodrich Petroleum (GDP) and Goodrich Petroleum (GDP). Who are iShares Diversified Alternatives Trust's key executives? iShares Diversified Alternatives Trust's management team includes the following people: Dr. Mitchel B. Sayare, Exec. Chairman (Age 72, Pay $65k)Dr. Vipin K. Garg, Pres, CEO & Director (Age 62, Pay $566.63k)Mr. William Michael Brown, CFO & Principal Accounting Officer (Age 38, Pay $443.16k)Dr. Matthew Scott Harris M.D., MS, FCAP, AGAF, Chief Medical Officer (Age 67, Pay $371.29k)Mr. Bertrand Georges Ph.D., Chief Technology Officer What is iShares Diversified Alternatives Trust's stock symbol? iShares Diversified Alternatives Trust trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "ALT." How do I buy shares of iShares Diversified Alternatives Trust? Shares of ALT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is iShares Diversified Alternatives Trust's stock price today? One share of ALT stock can currently be purchased for approximately $22.35. How big of a company is iShares Diversified Alternatives Trust? iShares Diversified Alternatives Trust has a market capitalization of $347.03 million. iShares Diversified Alternatives Trust employs 25 workers across the globe. What is iShares Diversified Alternatives Trust's official website? The official website for iShares Diversified Alternatives Trust is www.ishares.com. How can I contact iShares Diversified Alternatives Trust? iShares Diversified Alternatives Trust's mailing address is c/o BlackRock Asset Mgmt Internatnl Inc. 400 Howard Street, SAN FRANCISCO, CA 94105, United States. The company can be reached via phone at +1-415-6702000. This page was last updated on 7/12/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
